Pill Press & Encapsulating Machine Regulation
Current understanding
Federal law regulates tableting and encapsulating machines under the Controlled Substances Act, requiring importers/exporters to report transactions to DEA to deter illicit manufacture of counterfeit pills (notably fentanyl-laced tablets). Legislative proposals in 2025-2026 would expand this scope to cover critical parts, sellers, and deliverers, mandate permanent serial numbers, and criminalize serial number removal or knowing transport of machines with removed serial numbers.
Evidence log
- 2026-07-15 — Fight Illicit Pill Presses Act: 2025 — Fight Illicit Pill Presses Act (introduced) would extend CSA equipment controls to critical parts of tableting and encapsulating machines, require permanent serial numbers on machines and covered parts, and criminalize obliterating serial numbers or trafficking in machines with removed serials. (novelty: 3)
- 2025-10-14 — Preventing Illegal Laboratories and Protecting Public Health Act of 2025: cross-connection with preventing-illegal-laboratories-act: Both target clandestine drug manufacturing infrastructure and public health risks from illicit production. (novelty: 2)
- 2025-10-30 — Stop Pills That Kill Act: cross-connection with drug-scheduling-controlled-substances: Both target the illicit counterfeit pill supply chain — Stop Pills That Kill expands criminal penalties for counterfeit fentanyl manufacture, complementing pill-press equipment controls aimed at the same production infrastructure. (novelty: 2)
- 2025-09-18 — Fight Illicit Pill Presses Act: cross-connection with cossup-first-responder-fentanyl-exposure: Both address upstream disruption of illicit fentanyl supply — pill press controls target counterfeit tablet manufacture, while COSSUP grants address downstream first-responder exposure risks. (novelty: 3)